Clinical trials

The addition of targeted immunotherapy will be safe and well tolerated and facilitate the reduction of anthracycline exposure while preserving lymphoma disease control in children, adolescents and young adults (CAYA) with mature B-cell non-Hodgkin…

Investigator

William Slayton

Ages

3 Years - 39 Years

Sexes

All

Patients will receive a vaccine called SurVaxM on this study. While vaccines are usually thought of as ways to prevent diseases, vaccines can also be used to treat cancer. SurVaxM is designed to tell the body's immune system to look for tumor cells…

Investigators

Elias Sayour, Jennifer F King

Ages

1 Year - 21 Years

Sexes

All